+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Specificity and function of murine monoclonal antibodies and immunization-induced human polyclonal antibodies to lipopolysaccharide subtypes of Pseudomonas aeruginosa serogroup 06



Specificity and function of murine monoclonal antibodies and immunization-induced human polyclonal antibodies to lipopolysaccharide subtypes of Pseudomonas aeruginosa serogroup 06



Infection and Immunity 62(4): 1137-1143



Structural and antigenic heterogeneity has been noted among lipopolysaccharides (LPS) produced by Pseudomonas aeruginosa within serogroups previously considered to be serologically homogeneous. We characterized murine monoclonal antibodies (MAbs) and immunization-induced human polyclonal antibodies reactive with one or more of five structurally variant LPS subtypes belonging to serogroup 06 of the International Antigenic Typing System. Analyses of five different MAbs employing purified LPS or whole bacteria in enzyme-linked immunosorbent assays and Western blot (immunoblot) assays revealed five distinct patterns of subtype specificity, ranging from recognition of a single subtype to reactivity with all five. MAb-mediated opsonophagocytic killing and in vivo protection against live challenge in mice correlated, in general, with differential binding to various LPS subtypes. In comparison, sera from human vaccinees immunized with LPS-derived high-molecular-weight polysaccharide from P. aeruginosa Fisher immunotype 1, one of five serogroup 06 subtypes, exhibited LPS binding and opsonic activity against all five subtypes. Antibodies in the human sera effectively inhibited binding to all five LPS subtype antigens of the cross-reactive MAb, LC3-2H2, suggesting the existence of a common serogroup-related epitope. These findings emphasize the importance of defining subtype-associated variations in LPS antigenicity and corresponding differences in antibody specificity and function as a basis for designing immunoprophylactic or therapeutic strategies which target P. aeruginosa LPS.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 009443376

Download citation: RISBibTeXText

PMID: 8132318


Related references

Partial in vitro characterization of chimeric mouse-human monoclonal antibodies to Pseudomonas aeruginosa serogroup O6 lipopolysaccharide. Abstracts of the General Meeting of the American Society for Microbiology 96: 281, 1996

Production and characterization of a set of mouse-human chimeric immunoglobulin G (IgG) subclass and IgA monoclonal antibodies with identical variable regions specific for Pseudomonas aeruginosa serogroup O6 lipopolysaccharide. Infection and Immunity 66(9): 4137-4142, 1998

Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis. Journal Of Pediatrics. 127(5): 711-717, 1995

The use of bovine polyclonal and monoclonal antibodies and of murine monoclonal antibodies against PMSG for passive immunization in cattle. A comparative study and some preliminary results. Rapport Instituut voor Veeteeltkundig Onderzoek ' Schoonoord' ( B-308): 37pp., 1989

The use of bovine polyclonal and monoclonal antibodies and of murine monoclonal antibodies against PMSG for passive immunization in cattle. 1989

Characterization of murine monoclonal and murine, rabbit, and human polyclonal antibodies against chlamydial lipopolysaccharide. Infection and Immunity 58(1): 205-213, 1990

Murine monoclonal antibodies against core determinants of international type 6 pseudomonas aeruginosa lipopolysaccharide are opsonic and protective. Abstracts of the Annual Meeting of the American Society for Microbiology 85: 41, 1985

The protective activity of polyclonal and monoclonal antibodies to the lipopolysaccharide of Neisseria meningitidis serogroup A in in vivo experiments. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 1990(10): 118-121, 1990

Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis. Infection and Immunity 69(4): 2223-2229, 2001

Immunotherapy with human monoclonal antibodies. Fragment A specificity of polyclonal and monoclonal antibodies is crucial for full protection against tetanus toxin. Journal of Immunology 151(1): 466-472, 1993

Affinities of endotoxin-specific human monoclonal antibodies, their polyclonal counterparts and murine monoclonal antibodies. Research in Immunology 144(9): 659-665, 1993

Opsonic and protective activity of five human IgM monoclonal antibodies reactive with lipopolysaccharide antigen of Pseudomonas aeruginosa. Fems Microbiology Immunology 2(5-6): 263-268, 1990

Heterogeneity of the L-rhamnose residue in the outer core of Pseudomonas aeruginosa lipopolysaccharide, characterized by using human monoclonal antibodies. Infection and Immunity 57(6): 1691-1696, 1989

Variable region-identical monoclonal antibodies of different IgG subclass directed to Pseudomonas aeruginosa lipopolysaccharide O-specific side chain function differently. Journal of Infectious Diseases 167(1): 221-226, 1993

ELISAs for free light chains of human immunoglobulins using monoclonal antibodies: Comparison of their specificity with available polyclonal antibodies. Journal of Immunological Methods 275(1-2): 9-17, 1 April, 2003